Submission of Manuscripts
Manuscripts should be submitted only via the Online Manuscript Submission System in each Journal’s website as below:
Journal of Health Promotion Management’s Website: http://www.ijnr.ir
Nursing journals accepts Review Articles, Original Articles, Brief Reports, Case Reports and Letters to the editor in the field of Medical Sciences.
Peer Review Process
All submitted manuscripts will be pre-reviewed by INA editors in order to examine their format and scope. Manuscript will then be peer-reviewed by experts in the field. Editorial decision such as acceptance, rejection, or request for revision will be notified to the corresponding author. According to the policy of the journal the manuscripts will be reviewed within 2-4 weeks.
The word numbers of original articles should not be more than 3500 words excluding title page and references and the number of references should be less than 30. An original article should contain the following parts:
title page should contain the title of the manuscript, the name and affiliation of all authors, the affiliation, address, phone, fax and email address of corresponding author. Also it should contain a short title with less than 40 characters.
should have following section: Introduction, Materials and Methods, Results and Conclusion. Abstract must be less than 250 words. 3-5 keywords should be added at the end of the abstract.
should have following structure; Introduction, Materials and Methods, Results and Discussion.
acknowledge support received from individuals, organizations, grants, corporations, and any other source.
Conflict of Interest:
authors should state all financial and personal relationships that could be viewed as presenting a potential conflict of interest.
embed tables in the body of the text. Number tables in the order in which they are cited in the text and provide a title for each. Each table should be cited in the text. Explain all the abbreviations in footnotes.
Figures and Illustrations:
embed figures in the body of the text. Number figures in the order in which they are cited in the text and provide a legend for each. Figures should be cited in the text as Fig. only high quality figures and illustrations are acceptable.
cite references in the text, tables, and figures with numbers in brackets. Number references consecutively according to the order in which they first appear in the text. The first six author authors should be mentioned. The journals name should be abbreviated and in italic. At the end of the references which are indexed in PubMed the pubmed link must be added. Below there are examples of INA style for references.
You LM, Aiken LH, Sloane DM, Liu K, He GP, Hu Y, et al. Hospital nursing, care quality, and patient satisfaction: cross-sectional surveys of nurses and patients in hospitals in China and Europe. Int J Nurs Stud. 2013;50(6):154-61.
Murray RK, Granner D, Mayes P, Rodwell V. Harper’s biochemistry: Englewood Cliffs, New Jersey; 1990.
All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance or a department chair who provided only general support. Financial and material support should also be acknowledged. Please ensure that anyone acknowledged has granted permission to be listed.
Review articles should contain less than 5000 word count and not more than 50 references. The abstract and the body of the manuscript must be structured. The word count of abstract should be less than 300 words.
The word count of case report should be less than 2500 words and the number of references should be less than 20. The abstract should be structured containing Introduction, Case Presentation and Conclusion and should not exceed 200 words. The body of the manuscript should be structured as Introduction, Case Presentation and Discussion.
A competing interest exists when professional judgment concerning a primary interest (such as patients’ welfare or the validity of research) may be influenced by a secondary interest (such as financial gain or personal relationship). There is nothing inherently unethical about a competing interest but it should be acknowledged and openly stated.
It is recommended that all authors download and complete a copy of the ICMJE disclosure form, which is available as a PDF at www.icmje.org/coi_disclosure.pdf
. They should keep a copy of the form and send a copy to their corresponding author.
The corresponding author must insert within the submitted manuscript a summary statement headed “Competing Interests” at the end of the manuscript file (before the references) and in the. This will be included in the published article.
If no competing interests statement is submitted, or written the default statement on the published article will be ‘None declared’.
Ethical Approval of Research:
Our policy is to ensure that all articles published by INA report on work that is morally acceptable, and expects authors to follow the World Medical Association’s Declaration of Helsinki
In addition we welcome detailed explanations of how investigators and authors have considered and justified the ethical and moral basis of their work. If such detail does not easily fit into the manuscript please provide it in the covering letter or upload it as a supplemental file when submitting the article. We will also be pleased to see copies of explanatory information given to participants. Even if we do not include such detailed information in a final published version, we may make it available to peer reviewers and editorial committees. We already ask peer reviewers to consider and comment on the ethics of submitted work.
Clinical Trial Registration:
In accordance with the ICMJE Recommendations, INA will not consider reports of clinical trials unless they were registered prospectively before recruitment of any participants. This applies to trials which commenced after 1 July 2005; for older trials retrospective registration will be acceptable, but only if completed before submission of the manuscript to the journal.
Eligible trials have been defined by ICMJE since 1 July 2008 as “where human participants are prospectively assigned to one or more health-related interventions [including health services and behavioral interventions] to evaluate the effects on health outcomes”, and before that were defined more narrowly as trials “where human participants are prospectively assigned to investigate the cause and effect relationship between a medical intervention and health outcome”.
There are differing definitions of scientific misconduct. We deal with these problems at INA on a case by case basis while following guidance produced by bodies that include the Committee on Publication Ethics (COPE)
, the World Association of Medical Editors (WAME)
and The International Committee of Medical Journal Editors (ICMJE)
WAME gives a useful overview of misconduct, using a slightly amended version of the US Office of Research Integrity definition of scientific misconduct and including these behaviors:
Falsification of data:
ranges from fabrication to deceptive reporting of findings and omission of conflicting data, or wilful suppression and/or distortion of data.
The appropriation of the language, ideas or thoughts of another without crediting their true source and representation of them as one’s own original work.
Improprieties of authorship:
improper assignment of credit, such as excluding others, misrepresentation of the same material as original in more than one publication, inclusion of individuals as authors who have not made a definite contribution to the work published or submission of multi-authored publications without the concurrence of all authors.
Misappropriation of the ideas of others:
an important aspect of scholarly activity is the exchange of ideas among colleagues. Scholars can acquire novel ideas from others during the process of reviewing grant applications and manuscripts. However, improper use of such information can constitute fraud. Wholesale appropriation of such material constitutes misconduct.
Violation of generally accepted research practices:
serious deviation from accepted practices in proposing or carrying out research, improper manipulation of experiments to obtain biased results, deceptive statistical or analytical manipulations, or improper reporting of results.
Material failure to comply with legislative and regulatory requirements affecting research:
including but not limited to serious or substantial, repeated, wilful violations of applicable local regulations and law involving the use of funds, care of animals, human subjects, investigational drugs, recombinant products, new devices, or radioactive, biological or chemical materials.
Many journals, including INA journals, also include redundant publication and duplicate publication, lack of declaration of competing interests and of funding/sponsorship, and other failures of transparency to be forms of misconduct.
For further questions please contact the support team of INA: firstname.lastname@example.org
Submission Preparation Checklist